Overview

Ropivacaine Use in Femoral Nerve Block; What is the Minimal Effective Analgesic Concentration (MEAC 90)

Status:
Not yet recruiting
Trial end date:
2021-09-30
Target enrollment:
Participant gender:
Summary
The aim of this study is to determine the minimal effective ropivacaine concentration required to provide adequate analgesic femoral nerve block in 90% of patients (MEAC90)
Phase:
Phase 4
Details
Lead Sponsor:
Healthpoint Hospital
Treatments:
Ropivacaine